Xingsheng Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xingsheng Wang has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Beibei Fu
School of Life Sciences, Chongqing University, Chongqing, China
1 shared publication- Haibo Wu
School of Life Sciences, Chongqing University, Chongqing 401331, China
1 shared publication Haiwei Zhang
Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
1 shared publicationKelly Feldman
Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA
1 shared publicationKrishna Chaitanya Pavani
Department of Nutrition, Genetics and Ethology, Ghent University, Merelbeke, Belgium
1 shared publicationLei Shi
School of Life Sciences, Chongqing University, Chongqing, China
1 shared publication
Latest Publications
- Open Access
- 1 December 2023
- Published by KEAI Publishing in Green Energy & Environment
- Vol. 8 (6) , 1737-1752
Rare earth metal based DES assisted the VPO synthesis for n-butane selective oxidation toward maleic anhydride
- 1 December 2023
- Published by KEAI Publishing in Green Energy & Environment
- Vol. 8 (6) , 1737-1752
Open AccessRare earth metal based DES assisted the VPO synthesis for n-butane selective oxidation toward maleic anhydride
- 20 July 2021
- Published by Springer Nature in EMBO Reports
- Vol. 22 (9) , e52252
MiR-342 controls Mycobacterium tuberculosis susceptibility by modulating inflammation and cell death
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (Mtb) that places a heavy strain on public health. Host susceptibility to Mtb is modulated by macrophages, which regulate the balance between cell apoptosis and necrosis. However, the role of molecular switches that modulate apoptosis and necrosis during Mtb infection remains unclear. Here, we show that Mtb-susceptible mice and TB patients have relatively low miR-342-3p expression, while mice with miR-342-3p overexpression are more resistant to Mtb. We demonstrate that the miR-342-3p/SOCS6 axis regulates anti-Mtb immunity by increasing the production of inflammatory cytokines and chemokines. Most importantly, the miR-342-3p/SOCS6 axis participates in the switching between Mtb-induced apoptosis and necrosis through A20-mediated K48-linked ubiquitination and RIPK3 degradation. Our findings reveal several strategies by which the host innate immune system controls intracellular Mtb growth via the miRNA-mRNA network and pave the way for host-directed therapies targeting these pathways.
- 20 July 2021
- Published by Springer Nature in EMBO Reports
- Vol. 22 (9) , e52252
MiR-342 controls Mycobacterium tuberculosis susceptibility by modulating inflammation and cell death
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (Mtb) that places a heavy strain on public health. Host susceptibility to Mtb is modulated by macrophages, which regulate the balance between cell apoptosis and necrosis. However, the role of molecular switches that modulate apoptosis and necrosis during Mtb infection remains unclear. Here, we show that Mtb-susceptible mice and TB patients have relatively low miR-342-3p expression, while mice with miR-342-3p overexpression are more resistant to Mtb. We demonstrate that the miR-342-3p/SOCS6 axis regulates anti-Mtb immunity by increasing the production of inflammatory cytokines and chemokines. Most importantly, the miR-342-3p/SOCS6 axis participates in the switching between Mtb-induced apoptosis and necrosis through A20-mediated K48-linked ubiquitination and RIPK3 degradation. Our findings reveal several strategies by which the host innate immune system controls intracellular Mtb growth via the miRNA-mRNA network and pave the way for host-directed therapies targeting these pathways.